Weight loss intervention and follow-up in obese individuals

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500104257

Enrollment

Unknown

Registered

2025-06-13

Start date

2025-06-16

Completion date

Unknown

Last updated

2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

Group of obesity:NA

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 50 years (inclusive); 2. BMI between 28.0 kg/m² and 32.5 kg/m² (inclusive); 3. No gender restrictions; 4. Participants must provide informed consent and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Secondary obesity (e.g., Cushing's syndrome, hypothyroidism, growth hormone-secreting tumors, etc.); 2. Use of medications known to cause weight gain (e.g., corticosteroids, psychotropic drugs); 3. Conditions including pernicious anemia, malignancies, acute or chronic infections, severe liver or kidney dysfunction, severe cardiopulmonary diseases, cerebrovascular diseases, etc.; 4. Pregnancy or lactation.

Design outcomes

Primary

Measure	Time frame
Proteomics;Gut microbiome;Nuclear magnetic metabolomics;	—

Countries

China

Contacts

Public ContactJie Zhou

First Affiliated Hospital of Air Force Medical University

zhoujie@fmmu.edu.cn+86 29 8477 5217

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026